اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدSupervised machine learning based multi-task artificial intelligence classification of retinopathies
410
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Artificial intelligence (AI) classification holds promise as a novel and affordable screening tool for clinical management of ocular diseases. Rural and underserved areas, which suffer from lack of access to experienced ophthalmologists may particularly benefit from this technology. Quantitative optical coherence tomography angiography (OCTA) imaging provides excellent capability to identify subtle vascular distortions, which are useful for classifying retinovascular diseases. However, application of AI for differentiation and classification of multiple eye diseases is not yet established. In this study, we demonstrate supervised machine learning based multi-task OCTA classification. We sought 1) to differentiate normal from diseased ocular conditions, 2) to differentiate different ocular disease conditions from each other, and 3) to stage the severity of each ocular condition. Quantitative OCTA features, including blood vessel tortuosity (BVT), blood vascular caliber (BVC), vessel perimeter index (VPI), blood vessel density (BVD), foveal avascular zone (FAZ) area (FAZ-A), and FAZ contour irregularity (FAZ-CI) were fully automatically extracted from the OCTA images. A stepwise backward elimination approach was employed to identify sensitive OCTA features and optimal-feature-combinations for the multi-task classification. For proof-of-concept demonstration, diabetic retinopathy (DR) and sickle cell retinopathy (SCR) were used to validate the supervised machine leaning classifier. The presented AI classification methodology is applicable and can be readily extended to other ocular diseases, holding promise to enable a mass-screening platform for clinical deployment and telemedicine.
قيم البحث
اقرأ أيضاً
Purpose: In this work, we present a collaboration to create a validation dataset of pathologist annotations for algorithms that process whole slide images (WSIs). We focus on data collection and evaluation of algorithm performance in the context of e
stimating the density of stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. Methods: We digitized 64 glass slides of hematoxylin- and eosin-stained ductal carcinoma core biopsies prepared at a single clinical site. We created training materials and workflows to crowdsource pathologist image annotations on two modes: an optical microscope and two digital platforms. The workflows collect the ROI type, a decision on whether the ROI is appropriate for estimating the density of sTILs, and if appropriate, the sTIL density value for that ROI. Results: The pilot study yielded an abundant number of cases with nominal sTIL infiltration. Furthermore, we found that the sTIL densities are correlated within a case, and there is notable pathologist variability. Consequently, we outline plans to improve our ROI and case sampling methods. We also outline statistical methods to account for ROI correlations within a case and pathologist variability when validating an algorithm. Conclusion: We have built workflows for efficient data collection and tested them in a pilot study. As we prepare for pivotal studies, we will consider what it will take for the dataset to be fit for a regulatory purpose: study size, patient population, and pathologist training and qualifications. To this end, we will elicit feedback from the FDA via the Medical Device Development Tool program and from the broader digital pathology and AI community. Ultimately, we intend to share the dataset, statistical methods, and lessons learned.
Artificial intelligence (AI)-based methods are showing promise in multiple medical-imaging applications. Thus, there is substantial interest in clinical translation of these methods, requiring in turn, that they be evaluated rigorously. In this paper
, our goal is to lay out a framework for objective task-based evaluation of AI methods. We will also provide a list of tools available in the literature to conduct this evaluation. Further, we outline the important role of physicians in conducting these evaluation studies. The examples in this paper will be proposed in the context of PET with a focus on neural-network-based methods. However, the framework is also applicable to evaluate other medical-imaging modalities and other types of AI methods.
We used machine learning methods to predict NaV1.7 inhibitors and found the model RF-CDK that performed best on the imbalanced dataset. Using the RF-CDK model for screening drugs, we got effective compounds K1. We use the cell patch clamp method to v
erify K1. However, because the model evaluation method in this article is not comprehensive enough, there is still a lot of research work to be performed, such as comparison with other existing methods. The target protein has multiple active sites and requires our further research. We need more detailed models to consider this biological process and compare it with the current results, which is an error in this article. So we want to withdraw this article.
Artificial Intelligence is one of the fastest growing technologies of the 21st century and accompanies us in our daily lives when interacting with technical applications. However, reliance on such technical systems is crucial for their widespread app
licability and acceptance. The societal tools to express reliance are usually formalized by lawful regulations, i.e., standards, norms, accreditations, and certificates. Therefore, the TUV AUSTRIA Group in cooperation with the Institute for Machine Learning at the Johannes Kepler University Linz, proposes a certification process and an audit catalog for Machine Learning applications. We are convinced that our approach can serve as the foundation for the certification of applications that use Machine Learning and Deep Learning, the techniques that drive the current revolution in Artificial Intelligence. While certain high-risk areas, such as fully autonomous robots in workspaces shared with humans, are still some time away from certification, we aim to cover low-risk applications with our certification procedure. Our holistic approach attempts to analyze Machine Learning applications from multiple perspectives to evaluate and verify the aspects of secure software development, functional requirements, data quality, data protection, and ethics. Inspired by existing work, we introduce four criticality levels to map the criticality of a Machine Learning application regarding the impact of its decisions on people, environment, and organizations. Currently, the audit catalog can be applied to low-risk applications within the scope of supervised learning as commonly encountered in industry. Guided by field experience, scientific developments, and market demands, the audit catalog will be extended and modified accordingly.
This article reviews the Once learning mechanism that was proposed 23 years ago and the subsequent successes of One-shot learning in image classification and You Only Look Once - YOLO in objective detection. Analyzing the current development of Artif
icial Intelligence (AI), the proposal is that AI should be clearly divided into the following categories: Artificial Human Intelligence (AHI), Artificial Machine Intelligence (AMI), and Artificial Biological Intelligence (ABI), which will also be the main directions of theory and application development for AI. As a watershed for the branches of AI, some classification standards and methods are discussed: 1) Human-oriented, machine-oriented, and biological-oriented AI R&D; 2) Information input processed by Dimensionality-up or Dimensionality-reduction; 3) The use of one/few or large samples for knowledge learning.
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
